1. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35(12):519-530. doi:10.1542/pir.35-12-519.
2. Preterm birth. World Health Organization. Published February 19, 2018. Accessed June 23, 2020. https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
3. Sommer C, Resch B, Simões EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5(suppl2-M4):144-154. doi:10.2174/1874285801105010144.
4. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35(12):519-530. doi:10.1542/pir.35-12-519.
5. Pa Saidou Chaw, Lei Hua, Steve Cunningham, Harry Campbell, Rafael Mikolajczyk, Harish Nair, RESCEU Investigators, Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis, The Journal of Infectious Diseases, Volume 222, Issue Supplement_7, 1 November 2020, Pages S620–S627, https://doi.org/10.1093/infdis/jiz492
6. “Use of palivizumab in children with congenital heart disease.” Paediatrics & child health vol. 8,10 (2003): 631-6. doi:10.1093/pch/8.10.631
*Obwieszczenie Ministra Zdrowia z dnia 18 marca 2024 r. w sprawie wykazu refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych, https://dziennikmz.mz.gov.pl/actbymonths
#Aktualna Charakterystyka Produktu Leczniczego SYNAGIS®